Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
FASENRA Inj Lös 30 mg/ml Fertspr 1 ml
Drug
Fasenra, Injektionslösung in einer Fertigspritze
Schweres eosinophiles Asthma, EGPA
03.04.5. – other antiasthmatics
HAM – Human medicine
INLFS – Solution for injection in pre-filled syringe
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
6/8/2018
12/31/9999
Dosage strength
Fasenra 30 mg /1 ml, Injektionslösung in einer Fertigspritze
Schweres eosinophiles Asthma, EGPA
01
Z – approved
Package
7680665820019
No information made available
A/R – Authorised / referenced
1 pre-filled syringe(s)
001
Z – approved
Declaration
Component
30 mg benralizumabum
histidinum
histidini hydrochloridum monohydricum
trehalosum dihydricum
polysorbatum 20
aqua ad iniectabile
histidini hydrochloridum monohydricum
trehalosum dihydricum
polysorbatum 20
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
2538.90
None
Yes
10%
No
Authorisation holder
7601001348622
AstraZeneca AG
Neuhofstrasse 34
6340 Baar (ZG)
Neuhofstrasse 34
6340 Baar (ZG)
Date of revision of the text
11/11/2024
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.